A study for a 74 year old man who takes Crescormon, Flecainide Acetate, Panwarfin - from FDA reports
34 males aged 74 (±5) who take the same drugs are studied. This is a personalized study for a 74 year old male patient who has A-Fib, Congenital Afibrinogenemia. The study is created by eHealthMe based on reports from FDA.
How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.
Peer to Peer mobile support
Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.
34 males aged 74 (±5) who take Crescormon, Flecainide Acetate, Panwarfin are studied.
Number of reports submitted per year:
Information of the patient in this study:
- Age: 74
- Gender: male
- Conditions: A-Fib, Congenital Afibrinogenemia
- Drugs taken:
- Flecanide (None)
- Panwarfin (warfarin sodium)
- Crescormon (somatropin)
eHealthMe real world results:
Most common drug interactions over time
< 1 month:
- C-reactive protein increased
- Thrombocytopenia (decrease of platelets in blood)
- Anaemia (lack of blood)
- Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration)
- Hepatic enzyme abnormal
- Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
- Haematocrit decreased
- Nausea (feeling of having an urge to vomit)
1 - 6 months:n/a
6 - 12 months:n/a
1 - 2 years:n/a
2 - 5 years:n/a
5 - 10 years:n/a
- Loose stools
- Injection site erythema (redness at injection site)
- Idiopathic thrombocytopenic purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting)
- Hypertension aggravated (high blood pressure-aggravated)
- Blood albumin decreased
- Haematoma (collection of blood outside the blood vessels)
- Breast cancer recurrent
- Hepatic enzyme abnormal
Top conditions involved for these people *:
- Non-Hodgkin's Lymphoma Unspecified Histology Indolent Stage Iv (malignant (cancer) cells form in the lymph system- unspecified histology indolent stage iv): 3 people, 8.82%
- Multiple Myeloma (cancer of the plasma cells): 3 people, 8.82%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 8.82%
- Hepatitis B : 2 people, 5.88%
- Malnutrition (condition that results from eating a diet in which certain nutrients are lacking): 2 people, 5.88%
- Constipation : 2 people, 5.88%
- Dehydration (dryness resulting from the removal of water): 2 people, 5.88%
- Gastritis (inflammation of stomach): 2 people, 5.88%
- Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 1 person, 2.94%
- Bipolar Disorder (mood disorder): 1 person, 2.94%
Top co-used drugs for these people *:
- Lipitor (7 people, 20.59%)
- Zocor (6 people, 17.65%)
- Spiriva (5 people, 14.71%)
- Dexamethasone (5 people, 14.71%)
- Lanoxin (5 people, 14.71%)
- Tylenol (4 people, 11.76%)
- Lasix (4 people, 11.76%)
- Furosemide (4 people, 11.76%)
- Tikosyn (4 people, 11.76%)
- Metoprolol Tartrate (4 people, 11.76%)
* Some reports may have incomplete information.
You are not alone:
- Connect with people like you who take the same medications and have the same conditions
- Use your healthcare experience to help people like you, and be rewarded
What are the drugs?
- Crescormon has active ingredients of somatropin. (latest outcomes from Crescormon 7 users)
- Flecainide acetate has active ingredients of flecainide acetate. It is often used in atrial fibrillation/flutter. (latest outcomes from Flecainide acetate 4,877 users)
- Panwarfin has active ingredients of warfarin sodium. (latest outcomes from Panwarfin 25 users)
What are the conditions?
- A-fib (most common type of arrhythmia) can be treated by Warfarin sodium, Coumadin, Flecainide acetate, Digoxin, Pradaxa (latest reports from 225,638 A-fib patients)
- Congenital afibrinogenemia (blood does not clot normally due to a lack of or a malfunction involving fibrinogen) (latest reports from 17 Congenital afibrinogenemia patients)
- Crescormon and Flecainide acetate drug interaction
- Crescormon and Panwarfin drug interaction
- Flecainide acetate and Panwarfin drug interaction
FDA reports used in this study
- Want to find out more about the FDA reports used in the study? You can request them from FDA.
Recent general studies
- Will you have Hypertrophic Osteoarthritis with Warfarin Sodium? - now
- Will you have Heart Racing with Bifido? - now
- Will you have Erectile Dysfunction with Raptiva? - now
- Will you have Djd with Warfarin Sodium? - now
- Will you have Erectile Disturbance with Raptiva? - now
- Will you have Heart Pounding Or Racing with Bifido? - now
- Will you have Hemorrhoids with Skelaxin? - now
- Will you have Degenerative Joint Disease with Warfarin Sodium? - now
- Will you have Ed with Raptiva? - now
- Will you have Heart Pounding with Bifido? - now
Recent personal studies
- A study for a 18 year old boy who takes Concerta, Zoloft, Rexulti, Lamictal, Wellbutrin, Gabapentin - 29 minutes ago
- A study for a 18 year old boy who takes Concerta, Zoloft, Rexulti, Lamictal, Wellbutrin, Gabapentin - 42 minutes ago
- Prediction of Zoloft for a 18 year old girl - an hour ago
- A study for a 57 year old woman who takes Bayer Low Dose Aspirin (81mg Aspirin), Sertraline, Trelegy Ellipta, Plaquenil, Vitamin D, Loratadine - 2 hours ago
- Prediction of Tizanidine Hydrochloride, Celexa, Meloxicam, Propranolol Hydrochloride for a 23 year old woman - 4 hours ago
- A study for a 48 year old woman who takes Botox - 4 hours ago
- A study for a 69 year old man who takes Flonase, Symbicort - 5 hours ago
- A study for a 35 year old woman who takes Celebrex, Effexor Xr - 5 hours ago
- A study for a 63 year old man who takes Crestor, Metoprolol Tartrate, Bayer Low Dose Aspirin (81mg Aspirin) - 5 hours ago
- A study for a 33 year old man who takes Cephalexin, Loratadine - 6 hours ago
NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.